Provided by Tiger Trade Technology Pte. Ltd.

Merck

148.46
-1.8700-1.24%
Post-market: 148.28-0.1841-0.12%19:59 EDT
Volume:11.19M
Turnover:1.66B
Market Cap:366.28B
PE:116.64
High:149.60
Open:148.41
Low:146.28
Close:150.33
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.37
T/O Rate:0.45%
Dividend:3.32
Dividend Rate:2.24%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.73
PE(LYR):20.39

Loading ...

Merck & Co. on Track for Record High Close

Dow Jones
·
Jul 28

Merck KGaA (0O14) Receives a Hold from Jefferies

TIPRANKS
·
Jul 28

Barclays Adjusts Merck & Co. Price Target to $150 From $140, Maintains Overweight Rating

MT Newswires Live
·
Jul 28

Merck & Co Inc : Bernstein Raises Target Price to $105 from $100

THOMSON REUTERS
·
Jul 27

Will Merck’s (MRK) Early Royalty-Free HIV PrEP Licensing Strategy Redefine Its Global Health Narrative

Simply Wall St.
·
Jul 26

Is Merck (MRK) A Bargain After FDA Approval For LIPFENDRA And HIV PrEP Expansion?

Simply Wall St.
·
Jul 25

Merck Launches Early Access Initiative for Monthly Oral HIV Prevention Drug Alimatravir

Deep News
·
Jul 24

Aspen Pharmacare: Under Agreement, Co to Receive Technical Package from Msd, Together with Licensing Rights Covering 129 Countries

THOMSON REUTERS
·
Jul 24

Merck Outlines Access Plan for Investigational Monthly HIV Prevention Pill

MT Newswires Live
·
Jul 24

Gilead Sciences Says EMA Recommends Trodelvy-Keytruda Combination for Breast Cancer

MT Newswires Live
·
Jul 24

Merck announces initial access plans for alimatravir

TIPRANKS
·
Jul 24

Merck & Co - Signs Seven Voluntary Licensing Agreements with Generic Manufacturers in Africa and India

THOMSON REUTERS
·
Jul 24

Merck & Co - Royalty-free Agreements Enable Supply of Generic Alimatravir in 129 Lmics

THOMSON REUTERS
·
Jul 24

Merck Licenses Experimental HIV Pill to Generic Makers in 129 Countries

Reuters
·
Jul 24

Merck: Voluntary Licensing Agreements for Alimatravir Cover 129 Countries

THOMSON REUTERS
·
Jul 24

Merck: Plans Initial Alimatravir Supply Pending Regulatory Approval, Generic Manufacturing Ramp-up in Licensed Territories

THOMSON REUTERS
·
Jul 24

Merck: Announces Initial Access Plans for Alimatravir in Low- and Middle Income Countries for Prevention of Hiv-1

THOMSON REUTERS
·
Jul 24

Merck: in Active Discussions with Fiocruz on Alimatravir Availability in Latin America & Brazil

THOMSON REUTERS
·
Jul 24

Gilead’s Trodelvy plus Merck’s Keytruda recommended by CHMP in breast cancer

TIPRANKS
·
Jul 24

Merck & Co. Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24